Chronic administration of high doses of anticonvulsant drugs frequently produces classic osteomalacia with bone histologic changes characteristic of increased parathyroid hormone (PTH) effect in man. However, several reports have documented defects in calcified tissue metabolism suggestive of an end-organ resistance to PTH after chronic anticonvulsant drug therapy. To examine the direct action of anticonvulsant drugs on bone resorption, we investigated the effects of diphenylhydantoin (phenytoin) (DPH) (100-200 μg/ml) and phenobarbital (10-400 μg/ml) on basal and hormonally mediated resorption 5-day cultures of fetal rat forelimb rudiments. In this system both drugs significantly inhibited basal and PTH-stimulated 45Ca and [3H]hydroxyproline release, as well as 1,25-dihydroxyvitamin D3-stimulated 45Ca release. The effects of DPH and phenobarbital were additive, with DPH exhibiting a several-fold more potent inhibitory effect than phenobarbital. Whereas DPH exhibited a striking synergism with the inhibitory effects of human calcitonin (HCT) on PTH-induced resorption, the effect of phenobarbital was merely additive to that of HCT. PTH and PTH plus HCT-induced increases in bone cyclic AMP (cAMP) content were significantly inhibited by DPH but not by phenobarbital. However, in contrast to effects on 45Ca release, DPH inhibition of cAMP generation was not accentuated in the presence of HCT. It is concluded that: (a) both DPH and phenobarbital can directly inhibit basal and hormonally stimulated bone resorption, with DPH being much more potent in this regard; (b) DPH appears to inhibit bone resorption via a cAMP-independent mechanism and has an additional suppressive effect on PTH-induced cAMP generation; and (c) the synergistic interaction of DPH and HCT in inhibiting 45Ca release occurs at a site independent of cAMP generation.
Theodore J. Hahn, Cheryl R. Scharp, Catherine A. Richardson, Linda R. Halstead, Arnold J. Kahn, Steven L. Teitelbaum
Title and authors | Publication | Year |
---|---|---|
Bone Turnover Markers: Basic Biology to Clinical Applications.
Schini M, Vilaca T, Gossiel F, Salam S, Eastell R |
Endocrine reviews | 2023 |
Effects of zonisamide monotherapy on bone health in drug‐naive epileptic patients
DL Koo, H Nam |
Epilepsia | 2020 |
Bilateral Acetabular Fractures Associated with Seizures: A Report of 2 Cases
K Yngstrom, E Stapleton, Z Aberman, D Galos |
JBJS Case Connector | 2020 |
Bone health in pediatric patients with neurological disorders
A Ko, J Kong, F Samadov, A Mukhamedov, YM Kim, YJ Lee, SO Nam |
Annals of Pediatric Endocrinology & Metabolism | 2020 |
Phenobarbital inhibits osteoclast differentiation and function through NF-κB and MAPKs signaling pathway
W Wang, Y Gao, W Zheng, M Li, X Zheng |
International Immunopharmacology | 2019 |
Exposure to Excess Phenobarbital Negatively Influences the Osteogenesis of Chick Embryos
Y Yan, X Cheng, RH Yang, H Li, JL Chen, ZL Ma, G Wang, M Chuai, X Yang |
Frontiers in pharmacology | 2016 |
Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy
DL Koo, KJ Hwang, SW Han, JY Kim, EY Joo, WC Shin, HW Lee, DW Seo, SB Hong |
Epilepsy Research | 2014 |
Bone Status in Patients with Epilepsy: Relationship to Markers of Bone Remodeling
SA Hamed, EM Moussa, AH Youssef, MA ElHameed, E NasrEldin |
Frontiers in neurology | 2014 |
The problem of osteoporosis in epileptic patients taking antiepileptic drugs
B Miziak, B Błaszczyk, M Chrościńska-Krawczyk, G Danilkiewicz, E Jagiełło-Wójtowicz, SJ Czuczwar |
Expert Opinion on Drug Safety | 2014 |
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich |
Seldin and Giebisch's The Kidney | 2013 |
May Long Term Oxcarbazepine Treatment Be Lead to Secondary Hyperparathyroidism?
O Babacan, A Karaoglu, S Vurucu, E Yesilkaya, O Yesilyurt, T Cayci, M Gulgun, B Unay, R Akın, O Ozcan |
Journal of clinical neurology (Seoul, Korea) | 2012 |
Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy
DL Koo, EY Joo, D Kim, SB Hong |
Epilepsy Research | 2012 |
Generalised stunting of roots in an epileptic child: is long-term phenytoin therapy the cause?
G Jindal, RK Pandey, D Kumar |
BMJ case reports | 2012 |
Neuroendocrinological aspects of epilepsy: Important issues and trends in future research
AM Pack, DS Reddy, S Duncan, A Herzog |
Epilepsy & Behavior | 2011 |
Influences of bone and mineral metabolism in epilepsy
SA Hamed |
Expert Opinion on Drug Safety | 2011 |
Bone and calcium metabolism and antiepileptic drugs
A Verrotti, G Coppola, P Parisi, A Mohn, F Chiarelli |
Clinical Neurology and Neurosurgery | 2010 |
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
Evaluation of Bone Turnover in Epileptic Children Using Oxcarbazepine
A Cansu, E Yesilkaya, A Serdaroğlu, TL Hırfanoğlu, O Çamurdan, Ö Gülbahar, K Gücüyener, P Cinaz |
Pediatric Neurology | 2008 |
Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy
AM Pack, MJ Morrell, A Randall, DJ McMahon, E Shane |
Neurology | 2008 |
Adverse effects of antiepileptic drugs on bone mineral density in children
T Gissel, CS Poulsen, P Vestergaard |
Expert Opinion on Drug Safety | 2007 |
Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy
CA Kulak, VZ Borba, CE Silvado, L Paola, MJ Seibel, JP Bilezikian, CL Boguszewski |
Arquivos brasileiros de endocrinologia e metabologia | 2007 |
Dynamics of Bone and Cartilage Metabolism
JE Mulder, CA Kulak, E Shane |
Dynamics of Bone and Cartilage Metabolism | 2006 |
Adverse Effects of Antiepileptic Drugs on Bone Mineral Density
A Babayigit, E Dirik, E Bober, H Cakmakcı |
Pediatric Neurology | 2006 |
Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy
AM Pack, MJ Morrell, R Marcus, L Holloway, E Flaster, S Do�e, A Randall, C Seale, E Shane |
Annals of Neurology | 2005 |
Epilepsy, osteoporosis and fracture risk - a meta-analysis
P Vestergaard |
Acta Neurologica Scandinavica | 2005 |
International Review of Neurobiology
ZT Bloomgarden |
International review of neurobiology | 2005 |
Bilateral Acetabular Fractures Associated With a Seizure: A Case Report
R Friedberg, J Buras |
Annals of Emergency Medicine | 2005 |
Use of phenytoin for the long-term treatment of partial seizures: Results of a survey conducted during the 2004 meeting of the American Academy of Neurology
B Smith |
Current Therapeutic Research | 2005 |
Fracture Risk Associated with Use of Antiepileptic Drugs
P Vestergaard, L Rejnmark, L Mosekilde |
Epilepsia | 2004 |
Antiepileptic drugs and reduced bone mineral density
II Ali, L Schuh, GL Barkley, JR Gates |
Epilepsy & Behavior | 2004 |
Pathophysiology of bone loss in patients receiving anticonvulsant therapy
LA Fitzpatrick |
Epilepsy & Behavior | 2004 |
Adverse Effects of Antiepileptic Drugs on Bone Structure: Epidemiology, Mechanisms and Therapeutic Implications
AM Pack, MJ Morrell |
CNS Drugs | 2001 |
Phenyioin and Its Metabolite, 5-(4-Hydroxyphenyl)-5-Phenylhydantoin, Show Bone Resorption in Cultured Neonatal Mouse Calvaria
A Takahashi, K Onodera, H Shinoda, H Mayanagi |
The Japanese Journal of Pharmacology | 2000 |
Bone mineral density, vitamin D and anticonvulsant therapy
S Filardi, CA Guerreiro, LA Magna, JF Neto |
Arquivos de Neuro-Psiquiatria | 2000 |
Fracture risk is increased in epilepsy
P Vestergaard, S Tigaran, L Rejnmark, C Tigaran, M Dam, L Mosekilde |
Acta Neurologica Scandinavica | 1999 |
Osteoporosis
DL Glaser, FS Kaplan |
Spine | 1997 |
Endocrinology of Critical Disease
KP Ober |
1997 | |
Drug-Induced Metabolic Bone Disease
M Wolinsky-Friedland |
Endocrinology and metabolism clinics of North America | 1995 |
Phenytoin and fluoride act in concert to stimulate bone formation and to increase bone volume in adult male rats
T Ohta, JE Wergedal, T Matsuyama, DJ Baylink, |
Calcified Tissue International | 1995 |
Barbiturate and bone resorption
M Petrovic, G Cournot |
Calcified Tissue International | 1995 |
Low dose phenytoin is an osteogenic agent in the rat
T Ohta, JE Wergedal, HE Gruber, DJ Baylink, |
Calcified Tissue International | 1995 |
Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs
MJ Välimäki, M Tiihonen, K Laitinen, R Tähtelä, M Kärkkäinen, C Lamberg-Allardt, P Mäkelä, R Tunninen |
Journal of Bone and Mineral Research | 1994 |
The Effect of Phenytoin on Collagenase and Gelatinase Activities in UMR 106-01 Rat Osteoblastic Osteosarcoma Cells
AT Vernillo, NS Ramamurthy, HM Lee, BR Rifkin |
Matrix | 1990 |
The effect of phenytoin on parathyroid hormone stimulated cAMP activity in cultured murine osteoblasts
JM Auszmann, AT Vernillo, AS Fine, BR Rifkin |
Life Sciences | 1990 |
Reduction of the Teratogenic Effects of Phenytoin by Folic Acid and a Mixture of Folic Acid, Vitamins, and Amino Acids: A Preliminary Trial
M Zhu, S Zhou |
Epilepsia | 1989 |
Insulin and glucose regulation of glycogen synthase in rat calvarial osteoblastlike cells
EA Ituarte, HG Ituarte, TJ Hahn |
Calcified Tissue International | 1988 |
The effects of phenytoin on calcium uptake in osteoblastic cells
R Dziak, A Vernillo, B Rifkin |
Journal of Bone and Mineral Research | 1988 |
Glucose transport in osteoblast-enriched bone explants: Characterization and insulin regulation
TJ Hahn, SL Westbrook, TL Sullivan, WG Goodman, LR Halstead |
Journal of Bone and Mineral Research | 1988 |
Effect of phenytoin on rat bone resorption in vitro
MJ Somerman, BR Rifkin, S Pointon-Miska, WY Au |
Archives of Oral Biology | 1986 |
Diphenylhydantoin inhibits parathyroid hormone and prostaglandin E2-stimulated bone resorption in mouse calvaria without affecting cyclic AMP formation
U Lerner, BB Fredholm, L Hangstrom |
Journal of Oral Pathology and Medicine | 1985 |
Direct Effects of Diphenylhydantoin (Phenytoin) on the Ion-Transporting ATPases of Cultured Osteoblast-like Cells
RE Anderson, DM Woodbury |
Epilepsia | 1984 |
Phosphate and Mineral Metabolism
SG Massry, G Maschio, E Ritz |
1984 | |
Serum dihydroxyvitamin d metabolite concentrations in patients on chronic anticonvulsant drug therapy: Response to pharmacologic doses of vitamin D2
TJ Hahn, R Shires, LR Halstead |
Metabolic Bone Disease and Related Research | 1983 |
Oncogenic hypophosphatemic osteomalacia
ZS Agus |
Kidney International | 1983 |
Does carbamazepine cause disturbances in calcium metabolism in epileptic patients?
L Tjellesen, L Nilas, C Christiansen |
Acta Neurologica Scandinavica | 1983 |
Inhibition of bone resorption in tissue culture by H1-receptor antagonists
P Goldhaber, L Rabadjija |
American journal of physiology. Endocrinology and metabolism | 1983 |
A quantitative determination of anticonvulsant-induced bone demineralization by an improved X-ray densitometry technique
K Wolschendorf, K Vanselow, , H Schulz |
Neuroradiology | 1983 |
On the pathogenesis of anticonvulsant-drug-induced alterations of calcium metabolism
K Kruse |
European Journal of Pediatrics | 1982 |
Comparison of parathyroid hormone and calcium ionophore A23187 effects on bone resorption and nucleic acid synthesis in cultured fetal rat bone
TF DeBartolo, LE Pegg, C Shasserre, TJ Hahn |
Calcified Tissue International | 1982 |
Inhibition of 1α-hydroxy-vitamin D3stimulated bone resorption in tissue culture by the calcium antagonist verapamil
U Lerner, GT Gustafson |
European Journal of Clinical Investigation | 1982 |
Influence of Diphenylhydantoin on Isotope Release and Bone EnzymesIn Vitro
JG Pedersen, BJ Lund, I Reimann |
Acta Orthopaedica | 1982 |
Reduced bone growth in rats treated with anticonvulsant drugs: A type II pseudohypoparathyroidism?
PB Robinson, M Harris, W Harvey, N Papadogeorgakis |
Metabolic Bone Disease and Related Research | 1982 |
Disorders of Mineral Metabolism
RK Rude, FR Singer |
Disorders of Mineral Metabolism | 1982 |
Endokrinologie des Kindes- und Jugendalters
H Stolecke |
1982 | |
Endotoxin inhibition of macrophage-mediated bone resorption
AJ Kahn, SL Teitelbaum |
Calcified Tissue International | 1981 |
The Bone Inductive Capacity of Decalcified Bone Matrix Modified by Diphenylhydantoin
J Oikarinen |
Acta Orthopaedica | 1981 |
Vitamin D Assessment: The Assays and Their Applications
WE Duncan, JG Haddad |
Clinics in Laboratory Medicine | 1981 |
Influence of Diphenylhydantoin on Lysosomal Enzyme Release during Bone Resorption in Vitro
U Lerner, L Hänström |
Acta Pharmacologica et Toxicologica | 1980 |
Parathyroid hormone stimulates bone resorption via a Na–Ca exchange mechanism
NS Krieger, AH Tashjian |
Nature | 1980 |
6 Drug-induced disorders of vitamin D and mineral metabolism
TJ Hahn |
Clinics in Endocrinology and Metabolism | 1980 |
Ouabain Effects on Hormonally-Stimulated Bone Resorption and Cyclic AMP Content in Cultured Fetal Rat Bones
TJ Hahn, TF Debartolo, LR Halstead |
Endocrine Research | 1980 |
Phenobarbital-induced Alterations in the Metabolism of [3H]Vitamin D3 by the Perfused Rachitic Rat Liver In Vitro
DT Baran, AC Fausto, ML Roberts, I Karl, LV Avioli |
Journal of Clinical Investigation | 1979 |
Anticonvulsant drug-induced osteomalacia: Alterations in mineral metabolism and response to vitamin D3 administration
TJ Hahn, LR Halstead |
Calcified Tissue International | 1979 |
Disordered mineral metabolism produced by ketogenic diet therapy
TJ Hahn, LR Halstead, DC DeVivo |
Calcified Tissue International | 1979 |
Effect of lithium on parathyroid hormone-induced calcium release from bone rudiments
DT Baran, JK Burks, CA Richardson, JB Hamilton, LR Halstead, TJ Hahn, SL Teitelbaum, LV Avioli |
Calcified Tissue International | 1979 |
Cortisol enhancement of PTH-stimulated cyclic AMP accumulation in cultured fetal rat long bone rudiments
TJ Hahn, LR Halstead |
Calcified Tissue International | 1979 |
Symposium report — drugs and nutrition
AD Kenny |
Trends in Pharmacological Sciences | 1979 |
The effect of diphenylhydantoin upon the biosynthesis and degradation of collagen in cat palatal mucosa in organ culture
A Bergenholtz, L Hänström |
Biochemical Pharmacology | 1979 |